192 related articles for article (PubMed ID: 35514968)
1. Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-Up.
Niznik S; Rapoport MJ; Avnery O; Lubetsky A; Haj Yahia S; Ellis MH; Agmon-Levin N
Front Immunol; 2022; 13():843718. PubMed ID: 35514968
[TBL] [Abstract][Full Text] [Related]
2. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
[TBL] [Abstract][Full Text] [Related]
3. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
[TBL] [Abstract][Full Text] [Related]
5. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
6. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.
Radin M; Schreiber K; Costanzo P; Cecchi I; Roccatello D; Baldovino S; Bazzan M; Cuadrado MJ; Sciascia S
Int J Cardiol; 2017 Aug; 240():72-77. PubMed ID: 28385357
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
Ma J; Song H; Wei M; He Y
Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
[TBL] [Abstract][Full Text] [Related]
8. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
[TBL] [Abstract][Full Text] [Related]
9. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management.
Radin M; Ugolini-Lopes MR; Sciascia S; Andrade D
Semin Arthritis Rheum; 2018 Aug; 48(1):117-120. PubMed ID: 29395258
[TBL] [Abstract][Full Text] [Related]
10. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
[TBL] [Abstract][Full Text] [Related]
11. Heart valve disease in primary antiphospholipid syndrome.
Niznik S; Rapoport MJ; Avnery O; Kidon M; Shavit R; Ellis MH; Agmon-Levin N
Rheumatology (Oxford); 2024 May; 63(5):1397-1402. PubMed ID: 37572296
[TBL] [Abstract][Full Text] [Related]
12. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
Kopytek M; Natorska J; Undas A
Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome.
Stojanovich L; Djokovic A; Kontic M
Clin Exp Rheumatol; 2015; 33(4):531-6. PubMed ID: 26088955
[TBL] [Abstract][Full Text] [Related]
14. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.
Pablo RD; Cacho PM; López-Hoyos M; Calvo-Río V; Riancho-Zarrabeitia L; Martínez-Taboada VM
Clin Rev Allergy Immunol; 2022 Apr; 62(2):354-362. PubMed ID: 34216367
[TBL] [Abstract][Full Text] [Related]
16. Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort.
Zhao Y; Huang C; Qi W; Zhou Y; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507205
[TBL] [Abstract][Full Text] [Related]
17. The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study.
Radin M; Schreiber K; Cecchi I; Roccatello D; Cuadrado MJ; Sciascia S
Eur J Neurol; 2018 Feb; 25(2):320-325. PubMed ID: 29082583
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome-mediated acute cerebrovascular diseases and long-term outcomes.
García-Grimshaw M; Posadas-Pinto DR; Jiménez-Ruiz A; Valdés-Ferrer SI; Cadena-Fernández A; Torres-Ruiz JJ; Barrientos-Guerra JD; Amancha-Gabela M; Chiquete E; Flores-Silva FD; Cantú-Brito C
Lupus; 2022 Feb; 31(2):228-237. PubMed ID: 35042376
[TBL] [Abstract][Full Text] [Related]
19. Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study.
Del Barrio-Longarela S; Martínez-Taboada VM; Blanco-Olavarri P; Merino A; Riancho-Zarrabeitia L; Comins-Boo A; López-Hoyos M; Hernández JL
Clin Rev Allergy Immunol; 2022 Oct; 63(2):297-310. PubMed ID: 34910282
[TBL] [Abstract][Full Text] [Related]
20. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
